The Government Reform and Oversight Committee met alongside the House Veterans Affairs Committee to hear the testimony from DHMSM and GAO representatives on why the VA and DoD has failed to integrate its EHR systems, despite having spent billions in taxpayer dollars.
McKesson repots Q2 results: revenue up 10 percent to $49 billion, adjusted EPS $3.31 vs. $2.79, beating analyst expectations on both. McKesson also announces that its board has approved a $2 billion stock buy back plan.
CMS reports that the total claims submitted and total claims rejected since the ICD-10 transition are trending in line with historical ICD-9 averages.
Theranos announces a restructuring of its board of directors, reducing it from 12 to just five members and establishing a supplementary board of counselors and another board that will give medical advice.